The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
Abstract
BACKGROUND & AIMS The profile of chronic liver disease (CLD) in the United States has changed due to obesity trends and advances in treatment of viral hepatitis. We assessed liver transplant listing trends by CLD etiology. METHODS Adult candidates for liver transplantation were selected from the Scientific Registry of Transplant Recipients (2002 through 2019). We calculated proportion trends for common CLD etiologies at time of placement on the wait list, including chronic infection with hepatitis B virus, chronic infection with hepatitis C virus (HCV), nonalcoholic steatohepatitis (NASH, including cryptogenic cirrhosis), alcohol-related liver disease (ALD) without or with chronic HCV infection, autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, in patients with and without hepatocellular carcinoma (HCC). RESULTS From the 168,441 patients with known etiology and non-acute liver failure on the liver transplant waitlist, 27,799 patients (16.5%) had HCC. In 2002, the most common etiologies in patients without HCC were chronic HCV infection (37%) and ALD (16%), whereas only 5% had NASH. Among patients with HCC, 58% had chronic HCV infection and 10% had ALD and only 1% had NASH. In 2019, among patients without HCC, NASH was the second leading indication for liver transplantation (28% of patients), after ALD (38% of patients). Among patients with HCC, chronic HCV infection remained the leading indication (40% of patients) but NASH (24% of patients) surpassed ALD (16% of patients) to become the second leading indication. NASH was the leading indication in women without HCC (34%), in patients older than 54 years (36%), and in patients on Medicare (41%). In trend analysis, NASH was the most rapidly increasing indication for liver transplantation in patients without HCC (Kendall tau=0.97; P<.001) and in patients with HCC (tau=0.94; P<.0001). CONCLUSIONS In an analysis of data from the Scientific Registry of Transplant Recipients (2002 through 2019), we found NASH to be the second most common indication for liver transplant in 2019, and the fastest increasing indication. In 2019, NASH was the leading indication for liver transplantation among women without HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Self-citationYounossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235
Self-citation(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-642_1 · Cited by 2,081
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Self-citationLi, J., Zou, B., Yeo, Y. H., Feng, Y., Xie, X., Lee, D. H., Fujii, H., Wu, Y., Kam, L. Y., Ji, F., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30039-1 · Cited by 1,031
Self-citationYounossi, Z., Stepanova, M., Ong, J. P., Jacobson, I. M., Bugianesi, E., Duseja, A., Eguchi, Y., Wong, V. W., Negro, F., Yilmaz, Y., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.057 · Cited by 806
Self-citationPaik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020) · Hepatology · doi:10.1002/hep.31173 · Cited by 788
Self-citationHepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603
Noureddin, M., Vipani, A., Bresee, C., Todo, T., Kim, I. K., Alkhouri, N., Setiawan, V. W., Tran, T., Ayoub, W. S., Lu, S. C., et al. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0088-6 · Cited by 578
Epidemiology of chronic liver diseases in the USA in the past three decades
Younossi, Z. M., Stepanova, M., Younossi, Y., Golabi, P., Mishra, A., Rafiq, N., & Henry, L. (2020) · Gut · doi:10.1136/gutjnl-2019-318813 · Cited by 549
Self-citationSayiner, M., Koenig, A., Henry, L., & Younossi, Z. M. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.001 · Cited by 529
Self-citationGender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
Yang, J. D., Abdelmalek, M. F., Pang, H., Guy, C. D., Smith, A. D., Diehl, A. M., & Suzuki, A. (2014) · Hepatology · doi:10.1002/hep.26761 · Cited by 374
Le, M. H., Devaki, P., Ha, N. B., Jun, D. W., Te, H. S., Cheung, R. C., & Nguyen, M. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173499 · Cited by 287
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
Alexander, M., Loomis, A. K., Fairburn-Beech, J., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1103-x · Cited by 272
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes
Cholankeril, G., Wong, R. J., Hu, M., Perumpail, R. B., Yoo, E. R., Puri, P., Younossi, Z. M., Harrison, S. A., & Ahmed, A. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4684-x · Cited by 234
Self-citationMortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
Paik, J. M., Henry, L., De Avila, L., Younossi, E., Racila, A., & Younossi, Z. M. (2019) · Hepatology Communications · doi:10.1002/hep4.1419 · Cited by 225
Self-citationLee, B. P., Vittinghoff, E., Dodge, J. L., Cullaro, G., & Terrault, N. A. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.6536 · Cited by 205
Nonalcoholic fatty liver disease: Evolving paradigms
Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 197
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
Iqbal, U., Perumpail, B. J., Akhtar, D. H., Kim, D., & Ahmed, A. (2019) · Medicines · doi:10.3390/medicines6010041 · Cited by 162
Self-citationNonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting
Blais, P., Husain, N. S., Kramer, J. R., Kowalkowski, M. A., El‐Serag, H. B., & Kanwal, F. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.134 · Cited by 140
High Rates of Obesity and Non-Communicable Diseases Predicted across Latin America
Webber, L., Kilpi, F., Marsh, T., Rtveladze, K., Brown, M., & McPherson, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039589 · Cited by 140
Nguyen, M. H., Lim, J. K., Ozbay, A. B., Fraysse, J., Liou, I. W., Meyer, N. M., Dusheiko, G. M., & Gordon, S. C. (2018) · Hepatology · doi:10.1002/hep.30246 · Cited by 93
An update on liver transplantation: A critical review
Neuberger, J. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.021 · Cited by 81
The Depths of Despair Among US Adults Entering Midlife
Gaydosh, L. M., Hummer, R. A., Hargrove, T. W., Halpern, C. T., Hussey, J. M., Whitsel, E. A., Dole, N., & Harris, K. M. (2019) · American Journal of Public Health · doi:10.2105/ajph.2019.305002 · Cited by 76
Golabi, P., Bush, H., Stepanova, M., Locklear, C. T., Jacobson, I. M., Mishra, A., Trimble, G., Erario, M., Venkatesan, C., Younossi, I. M., et al. (2018) · Medicine · doi:10.1097/md.0000000000011518 · Cited by 73
Self-citationHester, D., Golabi, P., Paik, J. M., Younossi, I. M., Mishra, A., & Younossi, Z. M. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001172 · Cited by 65
Self-citationThe Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
Wong, C. R., & Lim, J. K. (2018) · Clinical Liver Disease · doi:10.1002/cld.721 · Cited by 64
Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population
Arshad, T., Golabi, P., Paik, J. M., Mishra, A., & Younossi, Z. M. (2018) · Hepatology Communications · doi:10.1002/hep4.1285 · Cited by 58
Self-citationThe impact of modifiable risk factors on the long‐term outcomes of non‐alcoholic fatty liver disease
Paik, J. M., Deshpande, R., Golabi, P., Younossi, I. M., Henry, L. L., & Younossi, Z. M. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15580 · Cited by 55
Self-citationKim, N. G., Nguyen, P. P., Dang, H., Kumari, R., García, G., Esquivel, C. O., & Nguyen, M. H. (2018) · Cancer · doi:10.1002/cncr.31373 · Cited by 52
Wieland, A. C., Quallick, M., Truesdale, A. E., Mettler, P., & Bambha, K. M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2740-8 · Cited by 51
Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies
Puchades, L., & Berenguer, M. (2018) · Hemodialysis International · doi:10.1111/hdi.12647 · Cited by 50
Younossi, Z. M., Blissett, D., Blissett, R. S., Henry, L. L., Younossi, Y., Beckerman, R., & Hunt, S. (2017) · Liver International · doi:10.1111/liv.13519 · Cited by 41
Self-citationNguyen, A. L., Park, H., Nguyen, P. P., Sheen, E., Kim, Y. A., & Nguyen, M. H. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5326-7 · Cited by 34
Ahmed, A., Gonzalez, S. A., Cholankeril, G. T., Perumpail, R. B., McGinnis, J. J., Saab, S., Beckerman, R., & Younossi, Z. M. (2017) · Hepatology · doi:10.1002/hep.29137 · Cited by 30
Self-citationSatapathy, S. K., Marella, H. K., Heda, R. P., Ganguli, S., Reddy, Y. K., Podila, P. S. B., Clark, I., & Maliakkal, B. J. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001735 · Cited by 14
Westphal, C., & Doblhammer, G. (2014) · Obesity Facts · doi:10.1159/000358738 · Cited by 12
Sanchez-Torrijos, Y. M., Ampuero, J., & Romero‐Gómez, M. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i15.697 · Cited by 9
Research works printed but not linked: 1
- Pol, 2019, The remarkable history of the hepatitis C virus, Genes Immun, 20, 436, 10.1038/s41435-019-0066-z · doi:10.1038/s41435-019-0066-z
Cited by
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
Self-citationRinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis
Loomba, R., Hartman, M. L., Lawitz, E. J., Vuppalanchi, R., Boursier, J., Bugianesi, E., Yoneda, M., Behling, C., Cummings, O. W., Tang, Y., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2401943 · Cited by 1,005
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Younossi, Z. M., Kalligeros, M., & Henry, L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0431 · Cited by 960
Self-citation
Metadata
- Authors
- Younossi, Z. M., Stepanova, M., Ong, J., Trimble, G., AlQahtani, S., Younossi, I., Ahmed, A., Racila, A., & Henry, L.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 19
- Issue
- 3
- Pages
- 580-589.e5
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W3034691659
- Cited by
- 576
- References
- 40
- FWCI
- 42.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- AbbVie
- Hennepin Healthcare Research Institute
- Bristol-Myers Squibb
- Gilead Sciences
- Novo Nordisk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.